The low platelet blood study
Recruiting
- Conditions
- ThrombocytopeniaHaematological Disorders
- Registration Number
- ISRCTN95606674
- Lead Sponsor
- niversity of Bristol
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 100
Inclusion Criteria
1. Age range >16 years old
2. Male and female
3. Low platelet count AND need for treatment
4. Hb>100g/l
Exclusion Criteria
1. Hb<100g/L
2. Patients unable to consent (e.g. due to mental incapacity)
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular pathways does ISRCTN95606674 investigate for predicting treatment responses in thrombocytopenia?
How do platelet function assays in this trial compare to standard-of-care biomarkers like CD61 or platelet count thresholds?
Which genetic or immunological biomarkers correlate with treatment outcomes in University of Bristol's thrombocytopenia study?
What adverse event profiles are associated with thrombocytopenia therapies validated through this observational trial's assays?
How might ISRCTN95606674's findings influence combination strategies with eltrombopag or romiplostim in immune thrombocytopenia?